Safety and Efficacy of Changing to DuoTrav in Patients Uncontrolled on Timolol
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to assess the safety and intraocular pressure (IOP)-lowering
efficacy of changing to DuoTrav® from prior timolol 0.5% monotherapy in participants with
open-angle glaucoma or ocular hypertension.